Table: Sapporo Clinical Lab - 9-MTH group results

Sapporo Clinical Laboratory

12/02/2025 06:36

Feb 12 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2024        Dec 31, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             15.28               14.85            19.80    
                 (+2.8 pct)          (-2.6 pct)       (+0.6 pct)  
  Operating        541 mln             414 mln          500 mln   
                 (+30.6 pct)         (-49.2 pct)      (-6.4 pct)  
  Recurring        553 mln             417 mln          493 mln   
                 (+32.4 pct)         (-57.0 pct)      (-4.2 pct)  
  Net              367 mln             311 mln          320 mln   
                 (+17.7 pct)         (-36.7 pct)      (-15.8 pct) 
  EPS            117.22 yen           93.67 yen       102.36 yen  
  Ann Div                             23.00 yen        23.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             23.00 yen        23.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T